US Patent 7419663 Treatment of complement-associated disorders

Patent 7419663 was granted and assigned to Genentech on September, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74196630

Patent Inventor Names

William I. Wood0

Mary A. Napier0

Menno Van Lookeren0

Sherman Fong0

Audrey Goddard0

Austin L. Gurney0

Avi Ashkenazi0

Daniel Tumas0

...

Date of Patent

September 2, 2008

Patent Application Number

109642630

Date Filed

October 12, 2004

Patent Primary Examiner

‌

David A. Saunders

Patent abstract

The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7419663 Treatment of complement-associated disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API